Johnson & Johnson

Merck traditionally has been a leader in vaccines but has not had success with a COVID-19 vaccine. It's lending a hand to Johnson & Johnson, where production is running significantly behind schedule.

Ohio providers are preparing to distribute more COVID-19 vaccines this week than ever.The U.S. Food and Drug Administration (FDA) authorized the COVID-19…

Come Thursday, Ohio will expand its list of eligible Ohioans who can sign up to receive the coronavirus vaccine. Phase 1C includes those with Type 1...

Johnson & Johnson has started shipping its first vaccine doses across the U.S., adding a third vaccine to the country's arsenal as public health officials warn of an uptick in cases.

Advisers to the Centers for Disease Control and Prevention voted to endorse the emergency use of a single dose of a vaccine made by Johnson & Johnson. A study showed it was 66% effective in the U.S.

The Food and Drug Administration gave Johnson & Johnson's vaccine the green light for emergency use Saturday, a day after a panel of advisers to the agency endorsed it in a unanimous vote.

The Food and Drug Administration released an analysis of Johnson & Johnson's COVID-19 vaccine Wednesday morning that appears to support its authorization for emergency use.

By some measures, the Johnson & Johnson vaccine may appear to be less effective than Moderna and Pfizer. But Dr. Ashish Jha says when it comes to hospitalizations and deaths, it's just as good.

The company's vaccine has shown to be 85% effective against severe forms of the disease. Patients will only need to receive one shot instead of two, as with other vaccines already in use in the U.S.

Portman will participate in a Phase 3 clinical trial for the coronavirus vaccine. He's the first senator to participate in a trial and hopes it will promote safety of vaccines once approved.